Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a development-stage medical technology company, today announced the appointment of Jerry DeCiccio, CPA, MBA, as Chief Financial Officer.
Related news for (SIGY)
- Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference
- Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference
- Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K
- Sigyn Therapeutics Completes Reverse Stock Split
- Sigyn Therapeutics Announces Reverse Stock Split